Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process

被引:119
作者
Gonzalez-Redondo, Rafael [1 ,2 ,3 ]
Garcia-Garcia, David [2 ,3 ]
Clavero, Pedro [1 ,2 ,3 ]
Gasca-Salas, Carmen [1 ,2 ,3 ]
Garcia-Eulate, Reyes [4 ]
Zubieta, Jose L. [4 ]
Arbizu, Javier [5 ]
Obeso, Jose A. [1 ,2 ,3 ]
Rodriguez-Oroz, Maria C. [1 ,2 ,3 ]
机构
[1] Clin Univ Navarra Med Sch, Dept Neurol, Pamplona, Spain
[2] CIMA, Neurosci Ctr, Pamplona, Spain
[3] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain
[4] Clin Univ Navarra Med Sch, Dept Radiol, Pamplona, Spain
[5] Clin Univ Navarra Med Sch, Dept Nucl Med, Pamplona, Spain
关键词
Parkinson's disease; dementia; mild cognitive impairment; FDG-PET; MRI; CEREBRAL GLUCOSE-METABOLISM; EARLY ALZHEIMERS-DISEASE; LEWY BODIES; ALPHA-SYNUCLEIN; DIAGNOSTIC-CRITERIA; NETWORK ACTIVITY; FDG-PET; DEMENTIA; BRAIN; HIPPOCAMPAL;
D O I
10.1093/brain/awu159
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Gonzalez-Redondo et al. use PET to compare the extent of atrophy versus hypometabolism in Parkinson's disease with cognitive deficits. In patients with mild cognitive impairment, hypometabolism exceeds atrophy in several cortical regions. In patients with dementia, hypometabolism in these areas is replaced by atrophy, surrounded by zones of hypometabolism.The pathophysiological process underlying cognitive decline in Parkinson's disease is not well understood. Cerebral atrophy and hypometabolism have been described in patients with Parkinson's disease and dementia or mild cognitive impairment with respect to control subjects. However, the exact relationships between atrophy and hypometabolism are still unclear. To determine the extension and topographical distribution of hypometabolism and atrophy in the different cognitive states of Parkinson's disease, we examined 46 patients with Parkinson's disease (19 female, 27 male; 71.7 +/- 5.9 years old; 14.6 +/- 4.2 years of disease evolution; modified Hoehn and Yahr mean stage 3.1 +/- 0.7). Cognitive status was diagnosed as normal in 14 patients, as mild cognitive impairment in 17 and as dementia in 15 patients. Nineteen normal subjects (eight female, 11 male; 68.1 +/- 3.2 years old) were included as controls. F-18-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging scans were obtained, co-registered, corrected for partial volume effect and spatially normalized to the Montreal Neurological Institute space in each subject. Smoothing was applied to the positron emission tomography and magnetic resonance imaging scans to equalize their effective smoothness and resolution (10 mm and 12 mm full-width at half-maximum and Gaussian kernel, respectively). Z-score maps for atrophy and for hypometabolism were obtained by comparing individual images to the data set of control subjects. For each group of patients, a paired Student's t-test was performed to statistically compare the two Z-map modalities (P < 0.05 false discovery rate corrected) using the direct voxel-based comparison technique. In patients with mild cognitive impairment, hypometabolism exceeded atrophy in the angular gyrus, occipital, orbital and anterior frontal lobes. In patients with dementia, the hypometabolic areas observed in the group with mild cognitive impairment were replaced by areas of atrophy, which were surrounded by extensive zones of hypometabolism. Areas where atrophy was more extended than hypometabolism were found in the precentral and supplementary motor areas in both patients with mild cognitive impairment and with dementia, and in the hippocampus and temporal lobe in patients with dementia. These findings suggest that there is a gradient of severity in cortical changes associated with the development of cognitive impairment in Parkinson's disease in which hypometabolism and atrophy represent consecutive stages of the same process in most of the cortical regions affected.
引用
收藏
页码:2356 / 2367
页数:12
相关论文
共 79 条
[1]   Neuropathology of dementia in Parkinson's disease: A prospective, community-based study [J].
Aarsland, D ;
Perry, R ;
Brown, A ;
Larsen, JP ;
Ballard, C .
ANNALS OF NEUROLOGY, 2005, 58 (05) :773-776
[2]   A systematic review of prevalence studies of dementia in Parkinson's disease [J].
Aarsland, D ;
Zaccai, J ;
Brayne, C .
MOVEMENT DISORDERS, 2005, 20 (10) :1255-1263
[3]   Parkinson disease neuropathology - Later-developing dementia and loss of the levodopa response [J].
Apaydin, H ;
Ahlskog, JE ;
Parisi, JE ;
Boeve, BF ;
Dickson, DW .
ARCHIVES OF NEUROLOGY, 2002, 59 (01) :102-112
[4]   Hippocampal, Caudate, and Ventricular Changes in Parkinson's Disease with and Without Dementia [J].
Apostolova, Liana G. ;
Beyer, Mona ;
Green, Amity E. ;
Hwang, Kristy S. ;
Morra, Jonathan H. ;
Chou, Yi-Yu ;
Avedissian, Christina ;
Aarsland, Dag ;
Janvin, Carmen C. ;
Larsen, Jan P. ;
Cummings, Jeffrey L. ;
Thompson, Paul M. .
MOVEMENT DISORDERS, 2010, 25 (06) :687-695
[5]   Unified segmentation [J].
Ashburner, J ;
Friston, KJ .
NEUROIMAGE, 2005, 26 (03) :839-851
[6]   A fast diffeomorphic image registration algorithm [J].
Ashburner, John .
NEUROIMAGE, 2007, 38 (01) :95-113
[7]   Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies [J].
Beyer, Mona K. ;
Larsen, Jan P. ;
Aarsland, Dag .
NEUROLOGY, 2007, 69 (08) :747-754
[8]   A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry [J].
Beyer, Mona K. ;
Janvin, Carmen C. ;
Larsen, Jan P. ;
Aarsland, Dag .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (03) :254-259
[9]   Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study [J].
Bohnen, Nicolaas I. ;
Koeppe, Robert A. ;
Minoshima, Satoshi ;
Giordani, Bruno ;
Albin, Roger L. ;
Frey, Kirk A. ;
Kuhl, David E. .
JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (06) :848-855
[10]   Evolution of mild cognitive impairment in Parkinson disease [J].
Broeders, M. ;
de Bie, R. M. A. ;
Velseboer, D. C. ;
Speelman, J. D. ;
Muslimovic, D. ;
Schmand, B. .
NEUROLOGY, 2013, 81 (04) :346-352